Upon binding to cereblon, IMiDs induce CRBN-dependent proteasomal degradation and inhibition of IKZF1/3, B cell-specific transcription factors required for both myeloma cell viability and activation of the immune system1,2,7. The gene discussed is CRBN; the disease is plasma cell myeloma.